- få varen levert rett hjem!
På lager. Sendes normalt fra oss i løpet av 10 virkedager
Om Multiple Myeloma and Other Plasma Cell N
Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration.